2-methoxyestradiol has been researched along with Acute Lymphoid Leukemia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chagraoui, J; Fares, I; Geoffrion, D; Gerby, B; Haman, A; Hébert, J; Hoang, T; Kosic, M; Krosl, J; Kwok, BH; Lavoie, G; Litalien, V; Maddox, PS; Marinier, A; Nourreddine, S; Ottoni, E; Ouellette, J; Roux, PP; Ryan, J; Sauvageau, G; Tremblay, M; Veiga, DF | 1 |
Cunningham, AM; Hibbs, DE; Kavallaris, M; Liaw, TY; McKay, MJ; Salam, NK | 1 |
2 other study(ies) available for 2-methoxyestradiol and Acute Lymphoid Leukemia
Article | Year |
---|---|
High-throughput screening in niche-based assay identifies compounds to target preleukemic stem cells.
Topics: 2-Methoxyestradiol; Animals; Basic Helix-Loop-Helix Transcription Factors; DNA-Binding Proteins; Estradiol; Humans; Jurkat Cells; LIM Domain Proteins; Mice; Neoplastic Stem Cells; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins; Receptor, Notch1; T-Cell Acute Lymphocytic Leukemia Protein 1; Transcription Factors; Tumor Microenvironment; Tumor Stem Cell Assay; Xenograft Model Antitumor Assays | 2016 |
Class I beta-tubulin mutations in 2-methoxyestradiol-resistant acute lymphoblastic leukemia cells: implications for drug-target interactions.
Topics: 2-Methoxyestradiol; Acetylation; Amino Acid Sequence; Cell Line, Tumor; Drug Resistance, Neoplasm; Estradiol; G2 Phase; Humans; Immunohistochemistry; Microscopy, Confocal; Mitosis; Models, Molecular; Molecular Sequence Data; Mutation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Structural Homology, Protein; Tubulin | 2008 |